World Health Organization (WHO)
Androgens have been used for the prevention of postpartum
breast pain and engorgement. However, because of the risk of rebound effect and
since only 10% of women benefit therapeutically from such intervention, the United
States Food and Drug Administration has requested manufacturers to stop labeling
preparations containing androgens for this indication. The World Health
Organization is not aware of similar action having been taken elsewhere.